{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:53:13Z","timestamp":1784875993195,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-09952-6","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T13:14:58Z","timestamp":1752671698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of optimal anti-proteinuric therapy on the prevention of diabetic kidney disease progression"],"prefix":"10.1038","volume":"15","author":[{"given":"Saed Ahmed","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molla Asnake","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getachew","family":"Wondafrash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rediet","family":"Ambachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukia Abukar","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias Tabit","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Missgana Worku","family":"Belete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misikr Alemu","family":"Eshetu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subah Abderehim","family":"Yesuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"9952_CR1","doi-asserted-by":"crossref","unstructured":"Schlosser J. Introduction: Standards of Medical Care in Diabetes\u20142022 [Internet]. Vol. 45, Diabetes Care. 2022. p. S1\u20132. Available from: https:\/\/diabetesjournals.org\/care\/article\/45\/Supplement_1\/S1\/138921\/Introduction-Standards-of-Medical-Care-in-Diabetes","DOI":"10.2337\/dc22-Sint"},{"issue":"5","key":"9952_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","volume":"102","author":"P Rossing","year":"2022","unstructured":"Rossing, P. et al. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 102(5), S1-127 (2022).","journal-title":"Kidney Int."},{"key":"9952_CR3","doi-asserted-by":"crossref","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease. 2017;12(18).","DOI":"10.2215\/CJN.11491116"},{"key":"9952_CR4","doi-asserted-by":"crossref","unstructured":"Hoogeveen EK. The Epidemiology of Diabetic Kidney Disease. 2022; 433\u201342.","DOI":"10.3390\/kidneydial2030038"},{"issue":"9","key":"9952_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cegh.2020.05.016","volume":"2021","author":"S Hussain","year":"2020","unstructured":"Hussain, S., Chand, M., Habib, A. & Hussain, S. Diabetic kidney disease\u202f: An overview of prevalence, risk factors, and biomarkers. Clin. Epidemiol. Glob. Heal. 2021(9), 2\u20136. https:\/\/doi.org\/10.1016\/j.cegh.2020.05.016 (2020).","journal-title":"Clin. Epidemiol. Glob. Heal."},{"key":"9952_CR6","doi-asserted-by":"publisher","unstructured":"Persson F, Rossing P. Diagnosis of diabetic kidney disease: state of the art and future perspective. Vol. 8, Kidney International Supplements. Elsevier Inc; 2018. p. 2\u20137. https:\/\/doi.org\/10.1016\/j.kisu.2017.10.003","DOI":"10.1016\/j.kisu.2017.10.003"},{"issue":"1","key":"9952_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcna.2012.10.001","volume":"97","author":"AT Reutens","year":"2013","unstructured":"Reutens, A. T. Epidemiology of diabetic kidney disease. Med. Clin. NA. 97(1), 1\u201318. https:\/\/doi.org\/10.1016\/j.mcna.2012.10.001 (2013).","journal-title":"Med. Clin. NA."},{"issue":"3","key":"9952_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1053\/j.ackd.2014.03.009","volume":"21","author":"V Harjutsalo","year":"2014","unstructured":"Harjutsalo, V. & Groop, P. H. Epidemiology and risk factors for diabetic kidney disease. Adv Chronic Kidney Dis. 21(3), 260\u2013266. https:\/\/doi.org\/10.1053\/j.ackd.2014.03.009 (2014).","journal-title":"Adv Chronic Kidney Dis."},{"issue":"6881","key":"9952_CR9","first-page":"134","volume":"266","author":"IDFD Atlas","year":"2019","unstructured":"Atlas, I. D. F. D. International diabetes federation. Lancet 266(6881), 134\u2013137 (2019).","journal-title":"Lancet"},{"issue":"1","key":"9952_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-018-3670-5","volume":"11","author":"F Wagnew","year":"2018","unstructured":"Wagnew, F. et al. Diabetic nephropathy and hypertension in diabetes patients of sub-Saharan countries: A systematic review and meta-analysis. BMC Res Notes. 11(1), 1\u20137. https:\/\/doi.org\/10.1186\/s13104-018-3670-5 (2018).","journal-title":"BMC Res Notes."},{"issue":"1","key":"9952_CR11","first-page":"8890331","volume":"2020","author":"WS Shiferaw","year":"2020","unstructured":"Shiferaw, W. S., Akalu, T. Y. & Aynalem, Y. A. Chronic kidney disease among diabetes patients in Ethiopia: A systematic review and meta-analysis. Int. J. Nephrol. 2020(1), 8890331 (2020).","journal-title":"Int. J. Nephrol."},{"key":"9952_CR12","doi-asserted-by":"crossref","unstructured":"Banerjee D, Winocour P, Chowdhury TA, Wahba M, Montero R, Fogarty D, et al. Management of hypertension and renin- angiotensin-aldosterone system blockade in adults with diabetic kidney disease\u202f: Association of British Clinical diabetologists and the renal association UK guideline update. 2022; 1\u201331.","DOI":"10.1186\/s12882-021-02587-5"},{"issue":"6","key":"9952_CR13","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/ki.2013.221","volume":"84","author":"DZI Cherney","year":"2013","unstructured":"Cherney, D. Z. I. et al. Long-term hemodynamic and molecular effects persist after discontinued renin-angiotensin system blockade in patients with type 1 diabetes mellitus. Kidney Int. 84(6), 1246\u20131253. https:\/\/doi.org\/10.1038\/ki.2013.221 (2013).","journal-title":"Kidney Int."},{"issue":"11","key":"9952_CR14","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.3390\/jcm4111908","volume":"4","author":"L Lozano-Maneiro","year":"2015","unstructured":"Lozano-Maneiro, L. & Puente-Garc\u00eda, A. Renin-angiotensin-aldosterone system blockade in diabetic nephropathy. Present evidences. J. Clin. Med. 4(11), 1908\u20131937 (2015).","journal-title":"J. Clin. Med."},{"issue":"1","key":"9952_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02314-y","volume":"18","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Real-world use of ACEI\/ARB in diabetic hypertensive patients before the initial diagnosis of obstructive coronary artery disease: Patient characteristics and long-term follow-up outcome. J. Transl. Med. 18(1), 1\u201313. https:\/\/doi.org\/10.1186\/s12967-020-02314-y (2020).","journal-title":"J. Transl. Med."},{"issue":"July","key":"9952_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2147\/TCRM.S325916","volume":"18","author":"A Shaikh","year":"2022","unstructured":"Shaikh, A., Ray, J. & Campbell, K. N. Role of finerenone in the treatment of diabetic kidney disease: Patient selection and clinical perspectives. Ther. Clin. Risk Manag. 18(July), 753\u2013760 (2022).","journal-title":"Ther. Clin. Risk Manag."},{"issue":"11","key":"9952_CR17","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/j.mayocp.2022.07.010","volume":"97","author":"CD Chu","year":"2022","unstructured":"Chu, C. D. et al. Submaximal angiotensin-converting enzyme inhibitor and angiotensin receptor blocker dosing among persons with proteinuria. Mayo Clin. Proc. 97(11), 2099\u20132106. https:\/\/doi.org\/10.1016\/j.mayocp.2022.07.010 (2022).","journal-title":"Mayo Clin. Proc."},{"key":"9952_CR18","doi-asserted-by":"publisher","unstructured":"Xie Q, Hao C, Ji L, Hu D, Zhu T, Li X. ACEI \/ ARB Underused in patients with type 2 diabetes in Chinese population ( CCMR-3B study ). 2015; https:\/\/doi.org\/10.1371\/journal.pone.0116970","DOI":"10.1371\/journal.pone.0116970"},{"key":"9952_CR19","unstructured":"IDF. The IDF Diabetes Atlas. Diabetes Res Clin Pract [Internet]. 2021 (10th ed). Available from: www.diabetesatlas.org"},{"key":"9952_CR20","doi-asserted-by":"publisher","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res. Clin. Pract. 2019;157: 107843. https:\/\/doi.org\/10.1016\/j.diabres.2019.107843","DOI":"10.1016\/j.diabres.2019.107843"},{"issue":"1","key":"9952_CR21","doi-asserted-by":"publisher","first-page":"21733","DOI":"10.1038\/s41598-021-01256-9","volume":"11","author":"MA Zeru","year":"2021","unstructured":"Zeru, M. A., Tesfa, E., Mitiku, A. A., Seyoum, A. & Bokoro, T. A. Prevalence and risk factors of type-2 diabetes mellitus in Ethiopia: Systematic review and meta-analysis. Sci. Rep. 11(1), 21733 (2021).","journal-title":"Sci. Rep."},{"issue":"4","key":"9952_CR22","first-page":"451","volume":"28","author":"A Zekewos","year":"2018","unstructured":"Zekewos, A., Loha, E., Egeno, T., Wubshet, K. & Merga, Z. Prevalence of diabetes mellitus and associated factors in southern Ethiopia: A community based study. Ethiop. J. Health Sci. 28(4), 451\u2013460 (2018).","journal-title":"Ethiop. J. Health Sci."},{"key":"9952_CR23","doi-asserted-by":"publisher","first-page":"117954681983941","DOI":"10.1177\/1179546819839418","volume":"13","author":"A Gu","year":"2019","unstructured":"Gu, A., Farzadeh, S. N., Chang, Y. J., Kwong, A. & Lam, S. Patterns of antihypertensive drug utilization among US adults with diabetes and comorbid hypertension: The national health and nutrition examination survey 1999\u20132014. Clin. Med. Insights Cardiol. 13, 1179546819839418 (2019).","journal-title":"Clin. Med. Insights Cardiol."},{"issue":"4","key":"9952_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s11606-009-1242-z","volume":"25","author":"Y Yang","year":"2010","unstructured":"Yang, Y. et al. High-risk diabetic patients in medicare part d programs: Are they getting the recommended ACEI\/ARB therapy?. J. Gen. Intern. Med. 25(4), 298\u2013304 (2010).","journal-title":"J. Gen. Intern. Med."},{"issue":"2\u20133","key":"9952_CR25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.healthpol.2010.11.010","volume":"100","author":"HL Yeh","year":"2011","unstructured":"Yeh, H. L., Huang, L. Y., Su, S., Yang, M. C. & Wang, T. C. Underuse of ACE inhibitors and angiotensin II receptor blockers among patients with diabetic nephropathy in Taiwan. Health Policy (New York). 100(2\u20133), 196\u2013202. https:\/\/doi.org\/10.1016\/j.healthpol.2010.11.010 (2011).","journal-title":"Health Policy (New York)."},{"issue":"2","key":"9952_CR26","first-page":"109","volume":"56","author":"SS Alavudeen","year":"2015","unstructured":"Alavudeen, S. S., Alakhali, K. M., Ansari, S. M. A. & Khan, N. A. Prescribing pattern of antihypertensive drugs in diabetic patients of Southern Province. Kingdom Saudi Arab. El patr\u00f3n de prescripci\u00f3n de los f\u00e1rmacos antihipertensivos en los pacientes diab\u00e9ti. 56(2), 109\u2013114 (2015).","journal-title":"Kingdom Saudi Arab. El patr\u00f3n de prescripci\u00f3n de los f\u00e1rmacos antihipertensivos en los pacientes diab\u00e9ti."},{"issue":"6","key":"9952_CR27","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/ndt\/gfy323","volume":"34","author":"T Suwabe","year":"2019","unstructured":"Suwabe, T. et al. Impact of glycemic control on the progression of diabetic nephropathy: A retrospective cohort study. Nephrol. Dial. Transpl. 34(6), 1020\u20131028. https:\/\/doi.org\/10.1093\/ndt\/gfy323 (2019).","journal-title":"Nephrol. Dial. Transpl."},{"issue":"1","key":"9952_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2019.107483","volume":"34","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y., Xu, L., Wang, X. & Wang, Y. Proteinuria as a modifiable risk factor for progressive renal decline in patients with type 2 diabetes mellitus. J. Diabetes Complicat. 34(1), 107483. https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.107483 (2020).","journal-title":"J. Diabetes Complicat."},{"issue":"2","key":"9952_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ekir.2020.11.011","volume":"6","author":"JR Kemp","year":"2021","unstructured":"Kemp, J. R., Conte, M. T. & Jackson, M. E. Emerging therapies in diabetic kidney disease: Focus on SGLT2 inhibitors and GLP-1 receptor agonists. Kidney Int. Rep. 6(2), 287\u2013296. https:\/\/doi.org\/10.1016\/j.ekir.2020.11.011 (2021).","journal-title":"Kidney Int. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09952-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09952-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09952-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T12:05:44Z","timestamp":1757246744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09952-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9952"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09952-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was granted by the Institutional Review Boards (IRB) of Yekatit 12 Hospital Medical College. The research was conducted in accordance with the Declaration of Helsinki. Strict measures were taken to maintain privacy and confidentiality, ensuring that no personal identifiers, including names, were recorded in the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The Institutional Review Board (IRB) of Yekatit 12 Hospital Medical College reviewed and approved this study. As the study involved the use of de-identified secondary data collected, the Yekatit 12 Hospital Medical College research ethical committee also granted a waiver of informed consent for both participation and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for participation and consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25791"}}